A diagnostic device that resembles a mammography unit can detect breast tumors as tiny as one-fifth of an inch in diameter, according to researchers at Mayo Clinic, who helped develop the technology along with industry collaborators Gamma Medica Inc. and GE Healthcare.

A prospective clinical study shows that the GeneSearch Breast Lymph Node Assay, a gene-based diagnostic test, has greater sensitivity than traditional intra-operative methods of detecting the spread of breast cancer to the lymph nodes. In the study, sponsored by Veridex LLC, the GeneSearch demonstrated overall sensitivity at least 10 percentage points higher than intra-operative tests.

IMCO-STAT, wireless communications technology software developed by IMCO Technologies, announced today that it has received FDA 510(k) clearance to sell to the healthcare industry, extending its presence in hospitals, imaging centers, medical clinics and orthopaedic practices.

The long-time dream of a vaccine to prevent breast cancer may be a step closer to reality, according to new research presented this week at the 29th Annual San Antonio Breast Cancer Symposium. Researchers presented the results of a vaccine
trial targeting HER2, a protein that is related to cell growth and is commonly overexpressed in breast cancer cells.

A Navy plan to test a blood substitute on civilian trauma victims should remain on hold, federal health advisers recommended Thursday, saying the experiment's risks outweigh its benefits.

The nonbinding vote appears to be the latest blow to the Navy, which has repeatedly sought FDA approval to test the product, derived from cow blood, on roughly 1,100 trauma victims in emergency situations. It proposes doing so without obtaining the customary informed consent of patients.

During last year's influenza season, the number of infants and toddlers in the U.S. who were vaccinated against the flu varied by tenfold between different locations, according to a new report.

Kathy Fredrickson, at the Arizona Department of Health Services, and associates tallied levels of vaccination among children 6 to 23 months old during the 2005-2006 flu season at sentinel sites in Arizona, Michigan, Minnesota, Montana, Oregon and the District of Columbia.

Quest Diagnostics Inc. has introduced its newly developed test, the Breast Cancer Gene Expression Ratio, to help physicians predict the risk of disease recurrence in women with estrogen receptor-positive, lymph node-negative breast cancer. Quest Diagnostics is the first company to develop a breast cancer recurrence test based on licensed gene-expression profiling technology from AviaraDx Inc., a molecular cancer profiling company.

3M announced the completion of the merger between its Health Information Systems division and SoftMed Systems Inc., a provider of health information management software.

Expression of two different proteins taken from primary tumor biopsies is highly associated with the spread of breast cancer to nearby lymph nodes, according to a new study. Researchers say this protein profile could help identify at an early stage those patients whose disease is likely to metastasize.

GE Healthcare today released the results of Omega Management Group’s 3rd quarter survey of GE customers - a survey revealing that nearly all users of the company’s Life Support Systems would recommend GE Services to their peers, and that more than nine out of 10 would purchase those services again in the future.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now